| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical management of HIV-1 resistance
|
Paredes, Roger
|
|
2010
|
85 |
1 |
p. 245-265
21 p.
|
article
|
| 2 |
Current status and challenges of antiretroviral research and therapy
|
Esté, José A.
|
|
2010
|
85 |
1 |
p. 25-33
9 p.
|
article
|
| 3 |
Development of topical microbicides to prevent the sexual transmission of HIV
|
Buckheit Jr., Robert W.
|
|
2010
|
85 |
1 |
p. 142-158
17 p.
|
article
|
| 4 |
Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides
|
Martin, John C.
|
|
2010
|
85 |
1 |
p. 34-38
5 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2010
|
85 |
1 |
p. ii-
1 p.
|
article
|
| 6 |
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
|
Blankson, Joel N.
|
|
2010
|
85 |
1 |
p. 295-302
8 p.
|
article
|
| 7 |
Entry inhibitors in the treatment of HIV-1 infection
|
Tilton, John C.
|
|
2010
|
85 |
1 |
p. 91-100
10 p.
|
article
|
| 8 |
Evaluation of antiretrovirals in animal models of HIV infection
|
Van Rompay, Koen K.A.
|
|
2010
|
85 |
1 |
p. 159-175
17 p.
|
article
|
| 9 |
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
|
Wensing, Annemarie M.J.
|
|
2010
|
85 |
1 |
p. 59-74
16 p.
|
article
|
| 10 |
HIV reservoirs, latency, and reactivation: Prospects for eradication
|
Dahl, Viktor
|
|
2010
|
85 |
1 |
p. 286-294
9 p.
|
article
|
| 11 |
In search of a selective therapy of viral infections
|
De Clercq, Erik
|
|
2010
|
85 |
1 |
p. 19-24
6 p.
|
article
|
| 12 |
Molecular basis of human immunodeficiency virus drug resistance: An update
|
Menéndez-Arias, Luis
|
|
2010
|
85 |
1 |
p. 210-231
22 p.
|
article
|
| 13 |
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
|
de Béthune, Marie-Pierre
|
|
2010
|
85 |
1 |
p. 75-90
16 p.
|
article
|
| 14 |
Notes to Authors
|
|
|
2010
|
85 |
1 |
p. CO3-
1 p.
|
article
|
| 15 |
Novel approaches to inhibiting HIV-1 replication
|
Adamson, Catherine S.
|
|
2010
|
85 |
1 |
p. 119-141
23 p.
|
article
|
| 16 |
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
|
Cihlar, Tomas
|
|
2010
|
85 |
1 |
p. 39-58
20 p.
|
article
|
| 17 |
Pharmacogenetics of antiretrovirals
|
Tozzi, Valerio
|
|
2010
|
85 |
1 |
p. 190-200
11 p.
|
article
|
| 18 |
Pharmacokinetics and drug–drug interactions of antiretrovirals: An update
|
Dickinson, Laura
|
|
2010
|
85 |
1 |
p. 176-189
14 p.
|
article
|
| 19 |
Running a tightrope: Regulatory challenges in the development of antiretrovirals
|
Naeger, Lisa K.
|
|
2010
|
85 |
1 |
p. 232-240
9 p.
|
article
|
| 20 |
Sexual transmission of HIV-1
|
Fox, Julie
|
|
2010
|
85 |
1 |
p. 276-285
10 p.
|
article
|
| 21 |
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
|
McColl, Damian J.
|
|
2010
|
85 |
1 |
p. 101-118
18 p.
|
article
|
| 22 |
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
|
Broder, Samuel
|
|
2010
|
85 |
1 |
p. 1-18
18 p.
|
article
|
| 23 |
The evolution of HIV treatment guidelines: Current state-of-the-art of ART
|
Zolopa, Andrew R.
|
|
2010
|
85 |
1 |
p. 241-244
4 p.
|
article
|
| 24 |
Understanding and managing the adverse effects of antiretroviral therapy
|
Hawkins, Trevor
|
|
2010
|
85 |
1 |
p. 201-209
9 p.
|
article
|
| 25 |
Update on antiretroviral therapy in paediatrics
|
Penazzato, Martina
|
|
2010
|
85 |
1 |
p. 266-275
10 p.
|
article
|
| 26 |
Viral hepatitis and HIV co-infection
|
Soriano, Vincent
|
|
2010
|
85 |
1 |
p. 303-315
13 p.
|
article
|
Journal description